{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:23:49Z","timestamp":1765887829572,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jjcc.2016.08.013","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T21:35:46Z","timestamp":1475271346000},"page":"830-835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Prognostic impact of homocysteine levels and homocysteine thiolactonase activity on long-term clinical outcomes in patients undergoing percutaneous coronary intervention"],"prefix":"10.1016","volume":"69","author":[{"given":"Ahmed","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomotaka","family":"Dohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Ogita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kurano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryunosuke","family":"Ohkawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kikuo","family":"Isoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Yatomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Daida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2016.08.013_bib0195","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/ije\/31.6.1268","article-title":"Homocysteine and coronary heart disease: the importance of a distinction between low and high risk subjects","volume":"31","author":"De Bree","year":"2002","journal-title":"Int J Epidemiol"},{"issue":"Suppl. 2","key":"10.1016\/j.jjcc.2016.08.013_bib0200","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1007\/PL00014300","article-title":"The metabolism of homocysteine: pathways and regulation","volume":"157","author":"Finkelstein","year":"1998","journal-title":"Eur J Pediatr"},{"issue":"2A","key":"10.1016\/j.jjcc.2016.08.013_bib0205","doi-asserted-by":"crossref","first-page":"28A","DOI":"10.1016\/j.amjcard.2005.11.013","article-title":"Current and future directions of cardiovascular risk prediction","volume":"97","author":"Smith","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0210","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1172\/JCI108350","article-title":"The pathogenesis of coronary artery disease. A possible role for methionine metabolism","volume":"57","author":"Wilcken","year":"1976","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0215","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4414\/smw.2006.11283","article-title":"Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about?","volume":"136","author":"Faeh","year":"2006","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0220","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0225","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","article-title":"Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project","volume":"277","author":"Graham","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0230","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/ije\/24.4.704","article-title":"Serum total homocysteine and coronary heart disease","volume":"24","author":"Arnesen","year":"1995","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0235","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/01.STR.0000074035.64365.2D","article-title":"Homocysteine and cerebral infarction in Finnish male smokers","volume":"34","author":"Fallon","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0240","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.1992.03490070059042","article-title":"A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians","volume":"268","author":"Stampfer","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0245","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archinte.158.8.862","article-title":"Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention","volume":"158","author":"Wald","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0250","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.4065\/83.11.1203","article-title":"Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis","volume":"83","author":"Humphrey","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0255","doi-asserted-by":"crossref","first-page":"655","DOI":"10.5551\/jat.17152","article-title":"Diagnostic criteria for dyslipidemia","volume":"20","author":"Teramoto","year":"2013","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0260","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.2040-1124.2010.00074.x","article-title":"Report of the committee on the classification and diagnostic criteria of diabetes mellitus","volume":"1","author":"Seino","year":"2010","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0265","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0270","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/clinchem\/47.12.2155","article-title":"New enzymatic colorimetric assay for total homocysteine","volume":"47","author":"Matsuyama","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0275","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cccn.2005.03.046","article-title":"Investigation of the relationship between atherosclerosis and paraoxonase or homocysteine thiolactonase activity in patients with type 2 diabetes mellitus using a commercially available assay","volume":"359","author":"Kosaka","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0280","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(98)11058-9","article-title":"Homocysteine and vascular disease","volume":"354","author":"Hankey","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0285","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s11064-014-1338-7","article-title":"Toxic effects of mildly elevated homocysteine concentrations in neuronal-like cells","volume":"39","author":"Curro","year":"2014","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0290","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/archinte.159.10.1077","article-title":"Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women","volume":"159","author":"Bostom","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0295","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM199707243370403","article-title":"Plasma homocysteine levels and mortality in patients with coronary artery disease","volume":"337","author":"Nygard","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0300","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/01.CIR.102.6.605","article-title":"Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes","volume":"102","author":"Stubbs","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0305","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4070\/kcj.2016.46.2.154","article-title":"Prognostic value of elevated homocysteine levels in Korean patients with coronary artery disease: a propensity score matched analysis","volume":"46","author":"Kwon","year":"2016","journal-title":"Korean Circ J"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0310","doi-asserted-by":"crossref","first-page":"e1001177","DOI":"10.1371\/journal.pmed.1001177","article-title":"Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias","volume":"9","author":"Clarke","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0315","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0320","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0325","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"Bonaa","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0330","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/euhj.2001.2962","article-title":"Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty","volume":"23","author":"Schnyder","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0335","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-0037-1613962","article-title":"Homocysteine as a risk factor for restenosis after coronary angioplasty","volume":"84","author":"Morita","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0340","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1161\/01.CIR.103.16.2048","article-title":"Relation of a common methylenetetrahydrofolate reductase mutation and plasma homocysteine with intimal hyperplasia after coronary stenting","volume":"103","author":"Kosokabe","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0345","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jama.288.8.973","article-title":"Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial","volume":"288","author":"Schnyder","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0350","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1067\/mhj.2000.107546","article-title":"Homocysteine, lipoprotein(a), and restenosis after percutaneous transluminal coronary angioplasty: a prospective study","volume":"140","author":"Miner","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0355","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000063113","article-title":"Effect of elevated homocysteine levels on clinical restenosis following percutaneous coronary intervention","volume":"97","author":"Hodish","year":"2002","journal-title":"Cardiology"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0360","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1096\/fasebj.13.15.2277","article-title":"Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels","volume":"13","author":"Jakubowski","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0365","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/mnfr.201300133","article-title":"Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transport","volume":"57","author":"Julve","year":"2013","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0370","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1074\/jbc.275.6.3957","article-title":"Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation","volume":"275","author":"Jakubowski","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0375","first-page":"4","article-title":"The correlation of homocysteine-thiolactonase activity of the paraoxonase (PON1) protein with coronary heart disease status","volume":"52","author":"Domagala","year":"2006","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.jjcc.2016.08.013_bib0380","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.clinbiochem.2009.02.017","article-title":"Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome","volume":"42","author":"Koubaa","year":"2009","journal-title":"Clin Biochem"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508716302076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508716302076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:57:44Z","timestamp":1760273864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508716302076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0914508716302076"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2016.08.013","relation":{},"ISSN":["0914-5087"],"issn-type":[{"type":"print","value":"0914-5087"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic impact of homocysteine levels and homocysteine thiolactonase activity on long-term clinical outcomes in patients undergoing percutaneous coronary intervention","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2016.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}